Evaluation of follow-up care for patients with brain cancer
Standard Follow-up Program (SFP) for Neuro-oncology Cancer Patients Treated With Radiotherapy
This study is trying to see how well follow-up care works for brain cancer patients after they receive radiation treatment, to help improve their outcomes and future therapies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Medical Center Groningen Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Groningen) |
| Trial ID | NCT06528912 on ClinicalTrials.gov |
What this trial studies
This observational study aims to standardize the evaluation of baseline data related to tumor, patient, and treatment characteristics, as well as follow-up data on tumor and clinical outcomes for neuro-oncology patients treated with radical radiotherapy. The study seeks to address the current knowledge gap regarding dose-effect relationships in brain tissues, which is crucial for optimizing patient selection for proton therapy and improving treatment techniques. By gathering comprehensive data, the study hopes to enhance understanding of treatment outcomes and inform future innovations in radiation therapy.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with neuro-oncological cancer who are scheduled to receive a specific dose of radiotherapy.
Not a fit: Patients who do not meet the inclusion criteria or are not receiving the specified radiotherapy dose may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved selection criteria for radiation therapy, resulting in better treatment outcomes for patients with neurological cancers.
How similar studies have performed: While there is limited data on this specific approach, similar studies focusing on dose-effect relationships in radiation therapy have shown promise in improving treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with neuro-oncological cancer * Patient receiving a radiotherapy dose XXX Gy Exclusion Criteria: * Failure to comply with any of the inclusion criteria
Where this trial is running
Groningen
- Umcg — Groningen, Netherlands (Recruiting)
Study contacts
- Study coordinator: Hiske vd Weide
- Email: h.l.van.der.weide@umcg.nl
- Phone: 050-3615632
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.